COVID-19 Variant Network – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
Babu, Mohan |
The University of Regina | Operating Grant | $100,000
CIHR Saskatchewan 2021
Read More
COVID-19 Variant Supplement – The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection
Mui, Alice L |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
Discovery of small molecules targeting SARS-CoV-2 frameshifting using a rapid yeast platform
Jan, Eric |
University of British Columbia | Project Grant | $445,230
CIHR British Columbia 2021
Read More
Upstream determinants of effective COVID‑19 response: tools development and application through a case study in British Columbia
Berman, Peter |
University of British Columbia | Project Grant | $118,575
CIHR British Columbia 2021
Read More
Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.
Richard, Stéphane |
Lady Davis Institute for Medical Research | Operating Grant | $309,250
CIHR Quebec 2021
Read More
Developing a novel vaccine against COVID-19
Divangahi, Maziar |
McGill University | Project Grant | $569,925
CIHR Quebec 2021
Read More
COVID-19 Variant Supplement – Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19
Xing, Zhou |
McMaster University | Operating Grant | $50,000
CIHR Ontario 2021
Read More
Proof of concept of wastewater-based surveillance for SARS-COV2 to mitigate secondary COVID‑19 disease transmission in First Nations in Alberta
Parkins, Michael D |
The University of Calgary | Other | $200,000
CIHR Alberta 2021
Read More
Development of a rapid and simple test to detect the COVID‑19 variants that can be used in remote areas and developing countries.
Tremblay, Jacques P |
Université Laval | Operating Grant | $199,125
CIHR Quebec 2021
Read More
COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
Liu, Peter P |
Ottawa Heart Institute Research Corporation | Operating Grant | $50,000
CIHR Ontario 2021
Read More